Study Reveals Mechanism by Which Gut Bacteria Enhance Intestinal Immunity

The study was led by Yingzi Cong, PhD, the Stanley Gradowski Professor of Gastroenterology, who also served as a senior and co-corresponding author.

The findings suggest that beneficial compounds produced by gut microbes can "train" the intestinal lining to maintain immune tolerance over time. Tianming Yu, PhD, the first and co-corresponding author of the paper, stated that their laboratory has shown keen interest in understanding how the gut microbiota influences immune responses at the intestinal mucosal surfaces. He noted that short-chain fatty acids (SCFAs), produced during fiber fermentation, are known for their anti-inflammatory properties within the intestine.

The research particularly focused on butyrate, a predominant SCFA. Yu explained that because much butyrate is quickly absorbed and metabolized by intestinal epithelial cells (IECs), its effect on underlying immune cells is limited. This led to questions about whether butyrate could influence immunity through IECs.

To explore this, researchers provided mice with butyrate in their drinking water for a specified period before stopping the treatment. Two weeks post-treatment, the CD4+ T-cells in the mice continued to show elevated levels of IL-10, an essential anti-inflammatory cytokine. Mice that had received butyrate also demonstrated greater resistance to chemically induced colitis, experiencing less weight loss, lower inflammatory markers, and reduced tissue damage, all reliant on IL-10 signaling.

The study revealed that these lasting effects were not due to changes in the gut microbiome. In experiments with germ-free mice, which lack all microbes, butyrate still facilitated a persistent immune-regulating environment.

Yu remarked that oral butyrate treatment fosters a sustained immunoregulatory response characterized by increased IL-10 production, even after the treatment ends, emphasizing that butyrate establishes an enduring intestinal environment independent of continuous microbial influence.

The research team scrutinized IECs further, as these cells form a vital barrier between the body and gut microbiome. Laboratory experiments showed that IECs exposed to butyrate significantly heightened IL-10 production in T-cells from both mouse and human samples.

Subsequent analyses aimed to identify molecules capable of conveying this prolonged signal, with N1-acetylspermidine emerging as a notable candidate. This compound was found to promote IL-10 production in T-cells and contributed to the immune-regulating effect linked to butyrate-exposed IECs.

The research challenges the notion that IECs only serve temporary roles as barriers and suggests they may retain lasting molecular records of beneficial microbial signals. Yu noted the significance of identifying mechanisms by which microbiota-derived metabolites can foster durable interactions between epithelial cells and T-cells.

The implications of this study may extend to inflammatory bowel disease after further research confirms the findings and examines their applicability to humans. Yu expressed interest in exploring how this metabolic pathway functions in human intestinal diseases, particularly among patients with inflammatory bowel disease.

The researchers plan to investigate additional metabolites that may play a role, as N1-acetylspermidine alone did not account for all observed immune-regulating activity.

Yu concluded by highlighting a potential shift in understanding the relationship between diet, metabolites from gut microbes, and intestinal health. He insisted that while many studies have explored how inflammation could impose harmful memories in epithelial cells, their findings suggest that beneficial microbial metabolites could equally establish protective programs within the epithelium.

Wenjing Yang, MD, PhD, was a co-first author, with additional contributions from Suxia Yao, MD, and Parambir Dulai, MD, all from the Center for Human Immunobiology. The study was supported by National Institutes of Health grants DK135193, DK124132, and DK145439.